2019 annual financial data
Marker Therapeutics 2019 Financial results
Direct answer
Revenue was 213,194 USD.
Operating income was -22,528,806 USD and net income was -21,427,964 USD.
Operating cash flow was -18,284,293 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 213,194 USD
- Operating income
- -22,528,806 USD
- Net income
- -21,427,964 USD
- Operating cash flow
- -18,284,293 USD
Explore related company data
View all 2019 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Marker Therapeutics financial years